Thursday, June 06, 2019 9:50:52 PM
I agree with you that VATE is the best positioned CBD Beverage stock and is setting up very well here
“the first publicly traded, national brand to launch both CBD-infused iced tea and CBD-infused iced coffee in the ready-to-drink beverages market”
VATE has moved from a low of .027 to a high of .058 over the past few weeks
But the day VATE hit .058 it only traded there for a few minutes and then went right back down into the .04s
VATE has spent 90% of the time during the past 2 weeks trading between .04-.05
Over the past few days the volume has decreased and VATE is moving sideways — this is textbook consolidation
Here are the lows of the past 5 trading days — .0425, .043, .043, .0415, .0415
Here are the highs of the past 4 trading days — .046, .049, .0475, .0475, .046
This is the expected consolidation phase after the very high volume runup
Many were calling for a cup and handle even before VATE broke .05 in May for the first time in 6 months, so there is nothing unusual or surprising about VATE’s price movement over the past week or so
RSI had been in the green zone for quite awhile, and along with a few other technical indicators, it has now been reset
More importantly than everything else is that VATE has transformed from a boring Hemp Coffee stock into an exciting RTD CBD Coffee and CBD Tea stock
How VATE traded as a Hemp Coffee stock with convertible debt and minimal revenue growth is not entirely irrelevant to the discussion, but it is largely so
There is no valid comparison between VATE as a CBD Beverage stock with no convertible debt and expecting 100% revenue growth in Q2 to VATE as a Hemp Coffee stock with convertible debt and flat growth
The launch of the CBD Beverages changed everything — that’s what the market’s response in May to the launch of CBD Coffee has already communicated to us
I’m looking for VATE to put in a bottom shortly, after which it will begin the next leg upwards towards the .07-.08 range
I’m in no hurry though
There’s no better identity in the cannabis sector right now than VATE’s as a RTD CBD Coffee and CBD Tea stock
And the CBD Iced Tea literally just launched this week
Kelly Distribution is only 1 distributor who got a head start on the field
The other 3 distributors have either just received their pallets of CBD Coffee and CBD Tea (Synergy) or will be receiving them within the next few days (Tappy and Outwest505)
So distribution has barely even started
VATE’s cans and bottles were only in Illinois in May, but in June they will also be in Wisconsin and New Mexico, too
I’m sure additional distributors in other states will be announced regularly this month as well
So I feel really good about VATE’s future and am thrilled that both CBD Beverages appears to be big hits with consumers
This is only the very beginning
There is tons of growth ahead
More distributors, more states, more flavors
Revenue has nowhere to go but vertical from here
Sleek
“the first publicly traded, national brand to launch both CBD-infused iced tea and CBD-infused iced coffee in the ready-to-drink beverages market”
VATE has moved from a low of .027 to a high of .058 over the past few weeks
But the day VATE hit .058 it only traded there for a few minutes and then went right back down into the .04s
VATE has spent 90% of the time during the past 2 weeks trading between .04-.05
Over the past few days the volume has decreased and VATE is moving sideways — this is textbook consolidation
Here are the lows of the past 5 trading days — .0425, .043, .043, .0415, .0415
Here are the highs of the past 4 trading days — .046, .049, .0475, .0475, .046
This is the expected consolidation phase after the very high volume runup
Many were calling for a cup and handle even before VATE broke .05 in May for the first time in 6 months, so there is nothing unusual or surprising about VATE’s price movement over the past week or so
RSI had been in the green zone for quite awhile, and along with a few other technical indicators, it has now been reset
More importantly than everything else is that VATE has transformed from a boring Hemp Coffee stock into an exciting RTD CBD Coffee and CBD Tea stock
How VATE traded as a Hemp Coffee stock with convertible debt and minimal revenue growth is not entirely irrelevant to the discussion, but it is largely so
There is no valid comparison between VATE as a CBD Beverage stock with no convertible debt and expecting 100% revenue growth in Q2 to VATE as a Hemp Coffee stock with convertible debt and flat growth
The launch of the CBD Beverages changed everything — that’s what the market’s response in May to the launch of CBD Coffee has already communicated to us
I’m looking for VATE to put in a bottom shortly, after which it will begin the next leg upwards towards the .07-.08 range
I’m in no hurry though
There’s no better identity in the cannabis sector right now than VATE’s as a RTD CBD Coffee and CBD Tea stock
And the CBD Iced Tea literally just launched this week
Kelly Distribution is only 1 distributor who got a head start on the field
The other 3 distributors have either just received their pallets of CBD Coffee and CBD Tea (Synergy) or will be receiving them within the next few days (Tappy and Outwest505)
So distribution has barely even started
VATE’s cans and bottles were only in Illinois in May, but in June they will also be in Wisconsin and New Mexico, too
I’m sure additional distributors in other states will be announced regularly this month as well
So I feel really good about VATE’s future and am thrilled that both CBD Beverages appears to be big hits with consumers
This is only the very beginning
There is tons of growth ahead
More distributors, more states, more flavors
Revenue has nowhere to go but vertical from here
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2019 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2019-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
